Top US court hears case on drugmaker disclosures

WASHINGTON, Jan 10 (Reuters) - U.S. Supreme Court justices on Monday questioned arguments that Matrixx Initiatives need not reveal early complaints about cold remedy Zicam in a case that could affect how much information drugmakers share with investors.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.